CD80 and cholestasis: We conclude that short-term cholestasis leads to a pro-inflammatory reaction mediated by CD80+ cells, while chronic tissue damage is associated with a shift to an increasing number of MDMs with a dominant anti-inflammatory CD163+ cell fraction.